Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Enara Health vs Royal Medical Center

Enara Health
Graded #221

Higher grade

vs+15.899999999999999
Royal Medical Center
Graded #492

Lower grade

The verdict

Enara Health takes it — 65.3/100 to 49.4/100.

Enara Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Enara Health (enarahealth.com), founded 2015 in San Mateo, CA, is a physician-led, insurance-based obesity medicine program that prescribes branded GLP-1 medications including Wegovy (semaglutide) and…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEnara Health +23
45
22
Dose & formulationEnara Health +11
53
42
Clinical oversightEnara Health +30
92
62
Labs & monitoringRoyal Medical Center +1
85
86
FulfillmentEnara Health +18
66
48
Contract termsEven
55
55
Enara Health · left barRoyal Medical Center · right bar

The numbers

MetricEnara HealthRoyal Medical Center
WeighScore65.3/10049.4/100
GradeCC
Scorecard rank#221#492
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosed$450/mo (2.5 mg dose, compounded)
Coverage6 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Enara Health

Graded #221 · C

Strengths

  • Prescribes FDA-approved branded GLP-1s (Wegovy, Zepbound) not compounded
  • Insurance-based with prior-auth coverage for over 65% of members
  • Board-certified obesity-medicine physicians
  • Comprehensive program: dietitian, coaching, metabolic and genetic testing
  • Established since 2015 with clinical track record

Where it loses points

  • Available in only six states via partner clinics
  • Requires in-network insurance; not a flat cash-pay option
  • Not a pure-telehealth nationwide service
  • Out-of-pocket cost varies by insurance coverage
  • No compounded budget alternative for the uninsured
Royal Medical Center

Graded #492 · C

Strengths

  • Physician founder Dr. Dagoberto Rodriguez, MD — Emory residency, former Coral Springs Medical Center chairman, U Miami faculty
  • Tirzepatide pricing fully itemized by dose tier ($450 / $650 / $800 / $1,100) — more transparent than 'starting at' floors
  • All-inclusive pricing bundles medication, supplies, injections, lab monitoring, and physician follow-ups
  • Broad catalog (HRT, TRT, peptides, ED, hair, vitamins) reflects an established multi-program clinic
  • Florida physician with 30+ years of practice — a strong physician-led care signal

Where it loses points

  • Operating legal entity not disclosed — only the 'Royal Medical Center' brand surfaced
  • Pharmacy partner not named — buyers can't verify licensure or 503A/503B status
  • No LegitScript badge displayed
  • States served not enumerated — site says 'nationwide' with no state list
  • Headline 'starting at $116/mo' conflicts with the actual $450/mo tirzepatide floor

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard